Company Description
Taro Pharmaceutical Inds (NYSE: TARO) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $1.6B, ranking #2,368 among all listed U.S. companies by market cap.
TARO stock has declined 100.0% over the past year. Shares last traded at $42.97.
This page provides a comprehensive overview of TARO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Taro Pharmaceutical Inds (TARO) stock last traded at $42.97. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $1.6B, TARO is classified as a small-cap stock with approximately 37.6M shares outstanding.
Latest News
Taro Pharmaceutical Inds has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, earnings. View all TARO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
TARO Company Profile & Sector Positioning
Taro Pharmaceutical Inds (TARO) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NYSE.